Page 2 - Fernando Perez Villatoro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A new genetic test developed at the University of Helsinki and Helsinki University Hospital helps identify ovarian cancer patients who benefit from PARP inhibitors, a type of targeted drug that could be effective against ovarian cancer, the .

Eteläuomen läiFernando perez villatoroAnniina farkkilaUniversity of helsinkiHelsinki university hospital